Search results
PROMOTED
How do worsening heart events dictate the long-term outcomes of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and can earlier intervention influence the disease trajectory in ATTR-CM? In this new sub-analysis from ATTRibute-CM, recorded onsite at ESC Heart Failure Congress (HFA) 2026, Prof Marianna Fontana (University College London, London, UK) sheds further light onto these…
View more
HFA 2026: Updates on ATTR-CM
Author(s):
Marianna Fontana
,
Added:
3 weeks ago
Video Series
Added:
1 month ago
Source:
Interventional Cardiology
Mirjam Boros, Radcliffe CardiologyDe-escalation of dual antiplatelet therapy (DAPT) is a strategy used to improve outcomes after percutaneous coronary intervention (PCI).¹˒² However, the impact of patient sex on the safety and efficacy of these strategies has been unclear. A new network meta-analysis published in the European Heart Journal has investigated these potential differences…
View more
Diego De la Eranueva Calvo
Research Area(s) / Expertise:
Author
Research Area(s) / Expertise:
Diego Manuel de la Eranueva
Research Area(s) / Expertise:
Author
Alejandro Gullón de la Roza
Research Area(s) / Expertise:
Author
Research Area(s) / Expertise:
Research Area(s) / Expertise:
Research Area(s) / Expertise: